N. Caeyers

EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Jos N. Hoes, Johannes W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2007 · 408 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

Nneoma Duru, Marlies C. van der Goes, J. W. G. Jacobs et al. · Annals of the Rheumatic Diseases · 2013 · 270 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

Marlies C. van der Goes, Johannes W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2010 · 193 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

Marlies C. van der Goes, J. W. G. Jacobs, Maarten Boers et al. · Annals of the Rheumatic Diseases · 2009 · 136 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Young people’s perspectives on patient-reported outcome measures in inflammatory arthritis: results of a multicentre European qualitative study from a EULAR task force

Erika Mosor, Paul Studenic, Alessia Alunno et al. · RMD Open · 2021 · 15 citations · Full text

Medicine, Clinical Sciences, Adolescent Health +15